Patents Examined by Scott Getzow
  • Patent number: 8478389
    Abstract: A parameter value is computed for a segment of a cardiac-related signal. In accordance with various example embodiments, a system includes a computer circuit configured to identify cardiac cycles within a segment of a cardiac-related signal, such as an ECG. At least one feature point is identified within the cardiac cycles. For each identified feature point, a signal-to-noise ratio (SNR) representative of the ratio of signal energy to noise energy is computed for a cardiac cycle subsegment containing the identified feature point. A validity characteristic of the feature point is determined based upon the signal-to-noise ratio, and a parameter value is computed by combining feature points contained within the segment, based upon the determined validity characteristics of the feature points.
    Type: Grant
    Filed: April 22, 2011
    Date of Patent: July 2, 2013
    Assignee: VivaQuant, LLC
    Inventors: Marina Brockway, Brian Brockway
  • Patent number: 8478413
    Abstract: A system and associated method deliver a respiration therapy. Stimulation pulses are delivered to activate a right portion of a patient's diaphragm and to activate a left portion of a patient's diaphragm. A control processor determines dyssynchrony of a respiratory response to the stimulation pulses and adjusts a stimulation control parameter controlling the delivering of the stimulation pulses in response to dyssynchrony of the respiratory response.
    Type: Grant
    Filed: July 27, 2011
    Date of Patent: July 2, 2013
    Assignee: Medtronic, Inc.
    Inventors: Mustafa Karamanoglu, Vincent E. Splett
  • Patent number: 8478390
    Abstract: Systems and methods for determining the coronary sinus vein branch location of a left ventricle electrode are disclosed. The systems and methods involve detecting the occurrence of electrical events within the patient's heart including sensing one or more of the electrical events with the electrode and then analyzing the electrical events to determine the electrode's position. The determination of electrode position may be used to automatically adjust operating parameters of a VRT device. Furthermore, the determination of electrode position may be made in real-time during installation of the electrode and a visual indication of the electrode position may be provided on a display screen.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: July 2, 2013
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Yinghong Yu, Jiang Ding, Jeng Mah, Julio C. Spinelli
  • Patent number: 8467882
    Abstract: An IMD may transition to an MRI mode automatically in response to detecting one or more conditions indicative of the presence of a strong magnetic field. Large static magnetic fields, such as those produced by an MRI device, may interact with the blood of a patient as it flows through the magnetic field to produce a voltage, a phenomenon referred to as the magnetohydrodynamic (MHD) effect. The voltage produced by the MHD effect is proportional to the strength of the magnetic field. As such, the voltage produced by blood flow in the strong magnetic field of an MRI device may result in a change in a characteristic of an electrogram (EGM). The IMD may detect the change in the characteristic of the EGM caused by the MHD effect and transition to operation in the MRI mode in response to at least the change in the EGM.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: June 18, 2013
    Assignee: Medtronic, Inc.
    Inventors: Michael L. Ellingson, Hyun J. Yoon, Ben W. Herberg
  • Patent number: 8467872
    Abstract: A medical device includes an energy storage device, a plurality of electrodes, a memory, a switching circuit, and a processing module. The energy storage device stores electrical energy for delivery of defibrillation therapy to a heart. The memory stores N therapy configurations, each of the N therapy configurations defining which of the plurality of electrodes are used to deliver defibrillation therapy and further defining a waveform to be applied during delivery of defibrillation therapy. The switching circuit is configured to connect the plurality of electrodes to the energy storage device.
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: June 18, 2013
    Assignee: Medtronic, Inc.
    Inventor: Scott A. Hareland
  • Patent number: 8465534
    Abstract: There are disclosed methods and apparatus for attachment and welding of tissue. In an embodiment, the apparatus includes an energy applicator configured to apply energy to generate heat within a target tissue to evaporate water to create dried tissue, and a thermally conductive material disposed adjacent the first tissue contacting surface or the second tissue contacting surface. The thermally conductive material may be configured for direct contact with the target tissue heated by the energy applicator. The thermally conductive material provides a high coefficient of thermal conductivity so as to evenly distribute heat within the targeted tissue area. Other embodiments are also disclosed.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: June 18, 2013
    Inventor: David A. Schechter
  • Patent number: 8460173
    Abstract: Devices and methods for treatment of a failing heart by reducing the heart wall stress. The device can be one which reduces wall stress throughout the cardiac cycle or only a portion of the cardiac cycle.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: June 11, 2013
    Assignee: Edwards Lifesciences, LLC
    Inventors: Cyril J. Schweich, Jr., Robert M. Vidlund, Todd J. Mortier
  • Patent number: 8457737
    Abstract: In a subcutaneous implantable cardioverter/defibrillator, cardiac arrhythmias are detected to determine necessary therapeutic action. Cardiac signal information is sensed from far field electrodes implanted in a patient. The sensed cardiac signal information is then amplified and filtered. Parameters such as rate, QRS pulse width, cardiac QRS slew rate, amplitude and stability measures of these parameters from the filtered cardiac signal information are measured, processed and integrated to determine if the cardioverter/defibrillator needs to initiate therapeutic action.
    Type: Grant
    Filed: September 13, 2011
    Date of Patent: June 4, 2013
    Assignee: Cameron Health, Inc.
    Inventors: Gust H. Bardy, William J. Rissmann, Alan H. Ostroff, Paul J. Erlinger, Venugopal Allavatam
  • Patent number: 8452386
    Abstract: The electrocardiograph (200) of the invention is suitable for capturing a twelve-lead electrocardiogram from signals representative of the cardiac activity of a patient and acquired with the help of at least nine electrodes. The electrocardiograph comprises a body (210) having a front face (211) and at least one arm (212, 213) suitable for being folded beside the body and pivotable about an axis that is substantially parallel to the front face. Each arm is adapted to form a variable dihedral angle with the front face so that the substantially concave surface (214) formed by the front face and the or each arm and having six precordial electrodes (201-206) distributed thereon, is capable of adapting to the patient's morphology so as to enable the precordial electrodes to be properly positioned on the patient's chest. The electrocardiograph also includes means enabling said good positioning of the precordial electrodes on the patient's chest to be maintained.
    Type: Grant
    Filed: June 25, 2008
    Date of Patent: May 28, 2013
    Assignee: Parsys
    Inventor: Alain Danteny
  • Patent number: 8452406
    Abstract: A neurostimulation system includes a neural stimulation lead having a proximal portion and a distal portion and including a plurality of electrodes along the distal portion. The plurality of electrodes are configured for positioning proximate a portion of the autonomic nervous system. A neural stimulation circuit, coupled to the plurality of electrodes, delivers neural stimulation pulses to the plurality of electrodes. A processor and controller is configured to control the neural stimulation circuit to deliver first neural stimulation pulses to each of a plurality of electrode configurations. Each electrode configuration includes one or more of the plurality of electrodes. The processor and controller is further configured to receive information related to motor fiber activity that is induced in response to delivery of the first neural stimulation pulses to each of the plurality of electrode configurations and to identify the electrode configurations that induce the motor fiber activity.
    Type: Grant
    Filed: August 29, 2011
    Date of Patent: May 28, 2013
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Shantha Arcot-Krishnamurthy, David J. Ternes, Jason Hamann, Juan Gabriel Hincapie Ordonez, Stephen Ruble
  • Patent number: 8452399
    Abstract: A constant current pacing apparatus and method for pacing uses, for example, H-bridge circuitry and a constant current source connected to the H-bridge circuitry. Further, for example, protection is provided from high voltage pulses applied to the patient via one or more other medical devices.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: May 28, 2013
    Assignee: Medtronic, Inc.
    Inventor: Kevin A. Wanasek
  • Patent number: 8447410
    Abstract: Applicant has proposed a combination of the subretinal and epiretinal methods by placing the electronics external to the eye, entering the eye through the pars plana and the piercing the retina (retinotomy) from inside the eye to stimulate subreintally. The present invention is an improved electrode array for subretinal stimulation. A hard polymer such as polyimide is biocompatible and strong for supporting an electrode array and supporting traces in a thin flex circuit array. In the present invention applicant takes advantage of the sharp nature of thin polyimide making a point on the end of the electrode array. This allows the flexible circuit electrode array to be both electrode array and surgical tool to cut the retinal and slide the array under the retina in a single action.
    Type: Grant
    Filed: October 25, 2007
    Date of Patent: May 21, 2013
    Assignee: Second Sight Medical Products, Inc.
    Inventors: Robert J. Greenberg, Mark S. Humayun
  • Patent number: 8447399
    Abstract: A system and method for managing and inhibiting cardiac remodeling in MI patients. Bi-ventricular stimulation is constantly provided with and without sensing to encourage normal pumping of the heart on a consistent basis. Pulses are administered using an anodal pulse followed by a cathodal pulse to stimulate cardiac muscle contraction. Stem cells are administered to MI areas to encourage regeneration of cardiac tissue in the damaged area. Stimulation may be provided to both healthy and compromised cardiac tissue.
    Type: Grant
    Filed: April 1, 2008
    Date of Patent: May 21, 2013
    Assignee: MR3 Medical, LLC
    Inventor: Morton M. Mower
  • Patent number: 8447408
    Abstract: A user, such as a clinician or the patient, uses a control device to manipulate at least one neurostimulation parameter. A mapping system uses a calibrated map to map the directional output of the control device to values of at least one stimulation parameter to allow the user to intuitively control the value of the parameter. In some embodiments, where a stimulation device is used to deliver spinal cord stimulation (SCS) therapy for example, the user manipulates a parameter to effect the location and/or strength of paresthesia experienced by the patient. In exemplary embodiments, the parameter values are combinations of electrodes, and the mapping system selects electrode combinations based on the output of the control device such that a direction of movement of paresthesia experienced by the patient corresponds to a direction of manipulation of a directional controller of the control device. The mapping system may calibrate the map based on patient paresthesia information received from a user.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: May 21, 2013
    Assignee: Medtronic, Inc.
    Inventors: Richard B. North, Jeffrey M. Sieracki
  • Patent number: 8447394
    Abstract: Various system embodiments comprise a neural stimulator and a controller. The neural stimulator is adapted to generate a stimulation signal adapted to elicit sympathetic activity at a neural target. The controller is adapted to control the neural stimulator to provide a physical conditioning therapy. The controller is adapted to control the neural stimulator to intermittently elicit sympathetic activity at the neural target. Other aspects and embodiments are provided herein.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: May 21, 2013
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Imad Libbus, Julio C. Spinelli, Joseph M. Pastore, Andrew P. Kramer
  • Patent number: 8439971
    Abstract: A tissue shaping device adapted to reshape target tissue adjacent to a lumen. In some embodiments, the device includes an expandable and contractable anchor, with the anchor having an adjustable height anchoring portion adapted to engage a wall of the lumen in at least first and second anchor heights, the anchoring portion being further adapted to be changed from the first anchor height to the second anchor height by a substantially proximally or a substantially distally directed actuation force. The invention is also a tissue shaping system including a tissue shaping device and a tool for adjusting the height of an anchor of the device. The invention also includes methods of using such tissue shaping devices and systems.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: May 14, 2013
    Assignee: Cardiac Dimensions, Inc.
    Inventors: David Reuter, Mark Mathis, Greg Nieminen, Cruz Beeson
  • Patent number: 8437853
    Abstract: An implantable medical device (IMD) may include a lead circuit including a first node configured to be coupled to a first lead that may be coupled to a first target tissue and including a second node configured to be coupled to a second lead that may be coupled to a second target tissue. The IMD may include an impedance unit that may determine at least one characteristic of coupled energy associated with the lead circuit, where the coupled energy may be produced by a source external to the IMD. The impedance unit may provide an impedance between the first node and the second node, where the impedance is selected based at least in part on a characteristic of the coupled energy. The impedance is selected to reduce the coupled energy or a negative effect associated with functionality of the IMD induced by the coupled energy.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: May 7, 2013
    Assignee: Cyberonics, Inc.
    Inventors: Dana Michael Inman, Randolph K. Armstrong, Scott A. Armstrong
  • Patent number: 8437858
    Abstract: A visual prosthesis system comprises a retina implant at least partly located in the interior of a patient's eye. The retina implant comprises an array of micro-contacts adapted for contacting ganglia of the patient's retinal tissue. The visual prosthesis system further comprises a data processing unit with an additional interface for receiving an external signal from an external signal source, the data processing unit being adapted for converting the external signal into corresponding stimulation data for the retina implant, and a wireless transmission unit adapted for transmitting the stimulation data to the retina implant via wireless transmission. The retina implant is adapted for receiving the stimulation data and for stimulating the micro-contacts according to the stimulation data.
    Type: Grant
    Filed: March 18, 2008
    Date of Patent: May 7, 2013
    Assignee: IMI Intelligent Medical Implants, AG
    Inventors: Marcus Dapper, Christian Martin Kopka
  • Patent number: 8437857
    Abstract: A neurostimulation paddle lead, method of neurostimulation, and neurostimulation system are provided. The neurostimulation paddle lead carries a plurality of electrodes comprising at least four columns of electrodes having a spacing between two inner electrode columns less than a spacing between the inner electrode columns and adjacent outer electrode columns. The inner electrode columns may also be longitudinally offset from the outer electrode columns. The methods and neurostimulation systems steer current between the electrodes to modify a medial-lateral electrical field created adjacent spinal cord tissue.
    Type: Grant
    Filed: September 4, 2008
    Date of Patent: May 7, 2013
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael Moffitt, Dongchul Lee, Kerry Bradley, David K. L. Peterson
  • Patent number: 8437862
    Abstract: An IMD may transition to an MRI mode automatically in response to detecting one or more conditions indicative of the presence of a strong magnetic field. Large static magnetic fields, such as those produced by an MRI device, may interact with the blood of a patient as it flows through the magnetic field to produce a voltage, a phenomenon referred to as the magnetohydrodynamic (MHD) effect. The voltage produced by the MHD effect is proportional to the strength of the magnetic field. As such, the voltage produced by blood flow in the strong magnetic field of an MRI device may result in a change in a characteristic of an electrogram (EGM). The IMD may detect the change in the characteristic of the EGM caused by the MHD effect and transition to operation in the MRI mode in response to at least the change in the EGM.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: May 7, 2013
    Assignee: Medtronic, Inc.
    Inventors: Hyun J. Yoon, Ben W. Herberg, Michael L. Ellingson